For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on December 2nd, 2021 | 10:37 CET
The world's stock markets have been very nervous in recent days and weeks. Especially with growth stocks, investors need nerves of steel at the moment - the prices are very volatile. In such unsettled times, one can sleep more soundly if one bets on companies that profit from megatrends. If there is also positive company news at the same time, all the better. This scenario is currently the case for hydrogen leader Plug Power and German biotech giant BioNTech. The latter has just reported an important step in the cancer field. But also, the still largely unknown Memiontec, as a specialist for water treatment, benefits from a megatrend and shines with growth and a record order backlog.Read
Commented by Fabian Lorenz on November 30th, 2021 | 11:13 CET
After the sell-off last Friday, the stock market lights are back on green as of Monday. Shares from the electromobility sector can also benefit from this. These include the shares of BYD, Standard Lithium and Graphano Energy. In addition to a technical countermovement, the three companies have recently published positive news. BYD has received a significant order from Spain, Standard Lithium has secured fresh capital and a well-known investor, and newcomer Graphano Energy is successfully pushing ahead with its graphite project.Read
Commented by Fabian Lorenz on November 26th, 2021 | 13:04 CET
Hydrogen shares are in demand again. The basis for the industry is the political will for hydrogen to become a central pillar of the energy transition. It applies to numerous industrialized countries, and Germany's new traffic light coalition will also stick to it. But there is also positive news from the companies in operational terms. Following ThyssenKrupp's plans to float its hydrogen division on the stock market, Plug Power has now reported a major order with charisma. That should also give new impetus to hydrogen shares such as First Hydrogen and Nel.Read
Commented by Fabian Lorenz on November 25th, 2021 | 12:44 CET
The Corona pandemic has been with us all for a good 18 months now, and there is no end in sight. While the industrialized countries are boosting their vaccines, large parts of the world's population have still not been vaccinated for the first time. That means that shares of manufacturers of vaccines or drugs against COVID-19 will continue to be the focus of investors. Driven by the booster and mandatory vaccination discussions, BioNTech has left the correction behind, and the share is marching towards EUR 300. Drug developer Cardiol Therapeutics should now pick up again after the successful capital increase. In any event, analysts see price potential. Vaccine developer Valneva benefits from the EU order but has not yet recovered from Tuesday's "flash crash".Read
Commented by Fabian Lorenz on November 18th, 2021 | 10:50 CET
Since the beginning of October, hydrogen stocks have been celebrating a terrific comeback. The sector has clearly left behind the strong correction since February 2021. Even the climate conference without concrete results cannot stop the rally. Even the steel and industrial group Thyssenkrupp is reportedly toying with the idea of listing its hydrogen electrolyzer business on the stock market. Because one thing is clear: More and more countries are relying on hydrogen for a successful energy turnaround. In Europe alone, electrolysis capacities for "green hydrogen" are to be multiplied to 40 gigawatts by 2030. The US investment bank Jefferies is correspondingly optimistic about the potential of hydrogen companies. The market will continue to grow significantly. The analysts' favorite is ITM Power, but Nel is also recommended. The same could soon apply to dynaCERT.Read
Commented by Fabian Lorenz on November 16th, 2021 | 12:56 CET
After two weeks, the climate conference in Glasgow has come to an end. The results are manageable. Although coal and other fossil fuels were declared to be phased out for the first time, the wording was watered down several times. For example, it was only possible to agree on a call that the use of coal-fired power plants without CO2 capture should be "gradually reduced". But even without concrete resolutions, one thing is sure: the energy turnaround is in full swing, and investor darlings Nel and Plug Power are again stepping on the gas. Defense Metals could be due for a reassessment after the completion of drilling.Read
Commented by Fabian Lorenz on November 11th, 2021 | 13:02 CET
The reporting season is drawing to a close. Overall, most companies have been convincing, and the stock markets have been very friendly in recent weeks. Bayer published positive quarterly figures, raised its forecast for the full year and thus convinced the analysts from DZ Bank. Sativa Wellness benefits from the boom around cannabis and CBD. The still-new boom is growing strongly and is already in the black. At TUI, the operating figures play less of a role. The development of the Corona figures and, thus, possible travel restrictions in the coming winter are more critical. Read more about all three shares here.Read
Commented by Fabian Lorenz on November 9th, 2021 | 13:17 CET
Leading politicians and industry leaders are meeting in Glasgow until November 12 for the climate conference. So far, however, there has been nothing more than "hot air" to report. Not only climate activists are disappointed. Even German Development Minister Gerd Müller criticized the interim results. "The emerging resolutions are not enough to achieve the 1.5-degree target," the CSU politician told Redaktionsnetzwerk Deutschland. There is also little news on the expansion of renewable energies. It is therefore not surprising that the oil price is picking up again. With a rise to USD 83.78, the price for the Brent variety has ended the correction. There is also no relief in sight for the price of gas. The shares of Gazprom and Saturn Oil & Gas are benefiting from this. But Nordex is also attracting attention with new orders.Read
Commented by Fabian Lorenz on November 4th, 2021 | 15:21 CET
The year-end rally in 2021 seems to have started in October. For technology stocks, in particular, it was a golden October. The leading index for tech stocks, the Nasdaq, clearly left its weak September phase behind and ended October at around 15,500 points. Technology stocks also started November strongly, raising hopes of a strong year-end rally. Tech stocks outside the US should also participate in this. HelloFresh surprised investors positively with an increase in its forecast, and the worst could be over for the problem child TeamViewer after the publication of its quarterly figures. The Aspermont share has not yet taken off. Analysts see clear potential for the Australian insider tip.Read
Commented by Fabian Lorenz on November 2nd, 2021 | 12:14 CET
Volkswagen, SMA Solar, Asos are just a few examples; hardly a day goes by without companies from a wide variety of industries complaining about shortages. Be it computer chips for the automotive industry, industrial raw materials for production or transportation options. But there are also winners. Among them is tungsten producer Almonty Industries with its project of the century in South Korea. Germany's Varta is looking to profit from the battery shortage, and excitement is building ahead of the numbers. And Valneva, after its successful capital increase, is hoping that corona vaccines will continue to be in demand.Read